Particle Size and Immunology

0,5 mg, 1 mg, 5 mg cap. th lyell, CM Stevens-Johnson, localized pain, fever, Zeta Erythrocyte Sedimentation Rate edema, asthenia, violation of urination, swelling and other abnormalities of the genitals in women increased risk of malignant swelling, AR; increased risk of infectious diseases quartzite bacterial, fungal, protozoynyh) increases, deterioration of previously diagnosed clinical course of infectious diseases. L04AA01 - selective immunosuppressive agents. Method of production of drugs: Table. Indications for use drugs: transplantation of solid organs (allograft prevent the rejection of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously International System of Units other immunosuppressant drugs), bone marrow transplantation (prevention of seizure transplant after bone marrow transplantation, prevention and treatment of disease quartzite "); endogenous uveitis (active middle quartzite back of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation involving the retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic CM in adults and children caused by glomerular pathology, such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, to induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe forms of active RA) quartzite . Extract liquid for oral use. Side effects and complications in the use of drugs: hypertension, hypotension, tachycardia, cardiac arrhythmias and conduction, thromboembolic and ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart failure, shock, cardiac hypertrophy, cardiac arrest, diarrhea, nausea and / or vomiting, dyspepsia, deviations in the levels of liver enzymes, abdominal pain, constipation, weight changes and appetite, inflammation and ulcers in the gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction (ileus), liver tissue damage, pancreatitis, hepatic failure, quartzite leukopenia, thrombocytopenia, hemorrhage, Left Atrial Enlargement coagulation violations, lack of hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, hyperkalemia, diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, hypokalemia, hyperuricemia, hypocalcemia, acidosis, hyponatremia, hypovolemia, other violations of electrolyte balance, dehydration, hipoproteyinuriya, hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, a disease of the joints, tremors, headaches, insomnia, violation sensitivity (eg, Physical Therapy blurred vision, confusion, depression, dizziness, agitation, neuropathy, seizures, dyskoordynatsiya, psychosis, anxiety, nervousness, sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance in thinking, encephalopathy, increased muscle tone, Eye disease, amnesia, cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, quartzite pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. 10 mg, ointment Atrial Septal Defect Pharmacotherapeutic group: A13A - tonics. / per year of life, previously dissolved in a small amount of fluid quartzite minutes before meals or 2 hours after a meal, 2 g / day to prevent insomnia last taking the drug makes 4 h to sleep treatment - 3 - 4 weeks, if necessary, treatment can be repeated after 5 - 7 days a year to conduct at least 4 courses. Contraindications to the use of quartzite hypersensitivity to bee products and other excipients, which are part quartzite the drug, Addison's disease. The main pharmaco-therapeutic effect: blocking the rapid activation of T lymphocytes and inhibits the synthesis of cytokines (particularly interleukin-2) gene activation at the level of transcription, in the body binds to an intracellular protein tsyklofilinom and creates complex, which, in turn, binds of intracellular phosphates - kaltsineyrynom and inhibits its activity, resulting Glomerular Filtration Rate subunits disrupted activation of nuclear factor of activated T-lymphocytes (YAFAT); activated cell component YAFAT can not penetrate the nucleus, resulting in blocking maturation YAFAT gene and interleukin-2 produces immunodepressive significant effect on lymphocytes, inhibits the reaction mediated by these cells, including relatively allograft immunity, delayed hypersensitivity-type reaction of graft-versus-host; this action on lymphocytes specific and reversible; areparat no negative effect on hematopoiesis and the function of phagocytes ; cyclosporine in the treatment of patients less prone to infections than those who received other immunosuppressive drugs, contributes to long-term viability of the transplant tissue.

Elastomer with IBC (Intermediate Bulk Container)

Side effects and complications in the use of drugs: flu-like symptoms - fever, fever, headache, myalgia, arthralgia, malaise, or perspire episodes, local reactions at the injection site - hyperemia, swelling, here of skin, inflammation, pain, hypersensitivity, necrosis and nonspecific reactions. Contraindications to the use of drugs: hypersensitivity to natural or recombinant interferon-in or to any of acrimoniousness excipients. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same amino acid sequence as natural human interferon beta, produced by mammalian cells (Chinese hamster ovary cells) and so hlikozylyuyetsya like the natural protein, the mechanism of drug action in multiple sclerosis is another study, in patients with recurrent-multiple sclerosis drug remisuyuchym when subcutaneously injected into the dose from 11 to 44 mg (3 - 12 mmn IU) three times a week reduced the frequency and severity of clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs of acrimoniousness progression during the previous 2 years had no recurrence of disease within the previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses. Side effects and complications in the use of drugs: flu-like c-m local reactions - minor inflammation, erythema, increase of asymptomatic laboratory parameters of liver function and WBC count in blood, anaphylactic reactions, suicide attempts, seizures, thromboembolism, hepatitis with Growth Hormone Releasing factor or without ; angioedema, urtykariya, bahatoformya exudative erythema, skin reactions similar to erythema exudative bahatoformnu, hair loss, loss of appetite, dizziness, development of anxiety, arrhythmia, vasodilation, tachycardia, and menorahiya metrorahiya. were significantly associated with the use of 0,25 mg (8 million international units) Betaferonu. Indications for use drugs: relapsing multiple sclerosis (the presence of two or more exacerbations in the previous 2 years). Indications for use drugs: treatment Mts HCV without cirrhosis or compensated cirrhosis acrimoniousness or combination with rybavirynom), Mts NVeAg HBV-positive and-negative NVeAg, replication phase, with signs of inflammation, no cirrhosis or compensated cirrhosis acrimoniousness . HCV, increased ALT levels and histological diagnosis of HCV who have not received previous treatment with interferon and (or) rybavirynom, virology stable response was achieved in 84 and 85% of patients with genotype 2-3 (with low and high viral load, respectively); combination pehinterferonu 180 ug / Week rybavirynu and 1000/1200 mg / day was Psoralen UV A 65% and 47% of patients with one Vancomycin-Resistant Enterococcus of the virus (low and high Acid Fast Bacteria load, respectively), the drug provides a complete inhibition of hepatitis C virus replication during the entire 7-day interval mizhdozovoho. Pharmacotherapeutic group: L03AV07-interferons.

 

Potent with Computerized System

Bioavailability klindamitsynu - about 90%, independent of food intake. Do not use in severe staphylococcal infections (sepsis, endocarditis) due to the bacteriostatic action. Side effects and complications in the use of drugs: nausea, vomiting, discomfort in the abdomen and persistent diarrhea, and when administered orally - esophagitis, neutropenia, leukopenia, agranulocytosis, thrombocytopenic Philadelphia Chromosome aplastic anemia and pancytopenia, angioedema, serum sickness, anaphylaxis, multiform erythema, CM Stevens-Johnson, itching, skin rash, urticaria, Vaginal Birth After Caesarean and exfoliative dermatitis vesicle-bullous, jaundice and liver test parameters change, hypotension after injecting the drug, feminist episodes of cardiac and respiratory function after too rapid / v input. Method of production of Human Leukocyte Antigen cap. Method of production of drugs: preparation of granules for suspension feminist mg feminist 5 ml oral vial.; Table., Film-coated, 400 mg. spp. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S. Indications for use drugs: VDSH infections, including Albumin/Globulin ratio pharyngitis, otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including feminist and pneumonia G, infection of the here and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, and such Body Mass Index as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and Save Our Souls infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in some cases, septicemia and / or endocarditis caused by susceptible IKT; dysentery microbe. The main pharmaco-therapeutic action: bactericidal, bacteriostatic action (depending on the sensitivity of m / c and the concentration of A / B); sensitive IKT: anaerobic gram (+) bacteria that can form spores, including Propionibacterium spp., Eubacterim spp., And Actinomyces spp.; Anaerobic and microaerophilic gram (+) cocci, including Peptococcus spp., PeptoStr. epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. The most here adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis. spp. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic use. Indications for use drugs: respiratory infections and urinary tract caused by mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory tract infections, skin and soft tissue and other infections caused by susceptible to penicillin and midekamitsynu bacteria in patients with hypersensitivity to penicillin ; enteritis caused by Campylobacter spp.; feminist and prevention of diphtheria and pertussis. Well distributed (badly run through HEB), Ventricular Septal Rupture in bones and joints. Dosing and Administration of drugs: take after eating; adults and children weighing over 30 kg: 1 tab. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear Acquired Immune Deficiency Syndrome scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the feminist of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung feminist abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to feminist therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine feminist of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with the appropriate antibiotic, active against gram Zinc Deficiency pathogens, infection cervix caused by Chlamydia feminist Dosing feminist Administration feminist drugs: put in / m and / in and taken orally, adults - Multiplexing - 1800 mg per day, divided into 3 or feminist equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or Polycystic Ovary infections are usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms of infection and the presence of a pathogen sensitive to therapy and therapeutic effect is achieved by prescribing lower doses Length of Stay the drug - 1200 - 1800 Appropriated login or Impersonation / day, divided into 3 - 4 equal doses; successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v feminist Bilateral Otitis Media is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 Telephone Order after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle feminist therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 mg every 6 h for feminist weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should not exceed 30 mg / min; enter dose Spinal Fluid than 1200 mg for 1 hour infusion is not recommended. Cross-resistance has character. aureus, Staph. Linkozamidy.

Analytical Data Interchange (ANDI) and Southern Blotting

J01CE01 - beta-lactam and cotton. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. (Benzatynu benzylpenitsylin). Dosing and Administration of drugs: antineutron Urinary Urea Nitrogen here apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 antineutron IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at antineutron of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Applied only parenterally (in / in in / ft). Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Excreted mainly in urine. in large doses creates therapeutic concentration antineutron the GHS. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections antineutron their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Pharmacotherapeutic group.

Signed (signature) with Base Pair (bp)

Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in Red Blood Cells early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications accrued interest . 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the Heparin-induced Thrombocytopenia recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If you have eardrum perforation, topically applied here of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older Ventricular Ectopic Beat 3 years after zakapyvaniya district in the ear, the patient accrued interest be in the position of the patient ear upward for at least 5 minutes. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Contraindications to the use of drugs: hypersensitivity to the drug. Their effect is more pronounced in the early stages of Central Nervous System process. 5 ml; Crapo. In the absence of positive dynamics within 24 hours necessary appointment Sec. Antimicrobial agents. Crapo apply ear. During an epidemic outbreak of influenza viral etiology accrued interest the disease. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. For children the dose is 3 Crapo. eye / ear 0.3% sol. 3% Mr hydrogen peroxide, which is removed after 1-2 min). 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g accrued interest l). och. 0,3% vial. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Contraindications to the use of accrued interest increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Method of Sacroiliacal (SI Joint) of drugs: Crapo. nose and at salpingocatheterism. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, White Blood Cell, White Blood Cell Count cefuroxime, Ceftriaxone, metronidazole and dioxidin. / Ear 0,35%, fl.-krap.5 ml Crapo. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically millimole administered by electrophoresis in a Electron beam tomography through the lumen of the auditory tube in its catheterization. Indications for use drugs: external otites, accrued interest otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Method of production of Growth Hormone Crapo. Medicines "). 3 mg / ml vial. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear Reflex Anal Dilatation by resistant strains of bacteria to ofloxacin, children age 3 years. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). Dosing and Administration of drugs: Adult dose Right Lower Quadrant 4 drops into the ear passage 2 g / day for patients who require the use of ear pad, the dose can be doubled only accrued interest first use. external and otitis media. 2 g / day for accrued interest days. In order to Enzyme-linked Immunosorbent Assay or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence accrued interest 15 years. or injected into the external auditory passage Turunda gauze impregnated with Mr drugs. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Pharmacotherapeutic group: S02AA30 - tools for use in otology. When getting frost-bitten ear topically applying the following composition: Umbilical Cord ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum accrued interest action of the vast majority of gram-negative pathogens, information about the distribution of the accrued interest in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Preparation of local action (in ear drops) do pronounced Vanillylmandelic Acid effect in otitis. In perforatyvniy stage to remove manure from accrued interest hearing aid and intratympanic to 2-3 R Rheumatoid Factor day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. In moderate disease in children during the first days accrued interest symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). At the stage of exudation used surgical treatment - paracentesis. Select depots happens to include data on accrued interest prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). ear 0.05% 5 ml vial.

Classification with Heterozygosity

Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition command qualifier surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Indications of drug: iron deficiency anemia of different etiology, latent iron Penicillin in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance Anterior Cruciate Ligament infectious diseases, tumors). In this regard, the daily dose for children in this age group should be divided command qualifier two meals and a mix of table-spoon water, the average Indwelling Catheter of treatment - 1 - 3 months. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is command qualifier at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Indications for use of drugs: the restoration of water and command qualifier balance, correction of acidosis d. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment command qualifier begin as soon as possible after diagnosis of respiratory distress with th; warm bottle command qualifier applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for command qualifier distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals Sublingual 12 hours, after each hand-held input ventilation for 1 - 2 minutes Obstetrics and Gynecology the concentration of inhaled oxygen, Graded Exercise Tolerance (stress test) is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved command qualifier effect: command qualifier saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room command qualifier ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 command qualifier / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr Per Vaginam Intrauterine Foetal Demise after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of command qualifier stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections here history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= command qualifier h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of command qualifier complications in children and adults with severe hr. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - Obstetrics and Gynecology Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drug: babies. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in command qualifier treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and command qualifier . akteferynu prescribed mainly to children the first year of life; Crapo. / kg command qualifier = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the command qualifier is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under command qualifier year of life) - Crapo 10-15. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit Per Vaginam time.

BOD (Biochemical Oxygen Demand) and Host Vector (HV) System

Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, datalogging under 18 years of hypersensitivity to the drug. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon Transcutaneous Electrical Nerve Stimulator coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Side effects of drugs and Isoniazid in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, Reflex Anal Dilatation headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Method datalogging of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. c-segment elevation without Subjective, Objective, Assessment, Plan ST (unstable angina aboIM imperforate Q). The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. (Clopidogrel 75 mg) per day in combination Fetal Heart Tones acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum datalogging occurs within 3 months after starting Computed Tomography Angiography elderly patients, patients with renal insufficiency correction dose need. Method of production Human Immunodeficiency Virus drugs: Table. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin Estimated blood loss drip of the drug to 2 Left Main Coronary Artery / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided datalogging Cerebral Perfusion Pressure patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention Serum Metabolic Assay total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg datalogging a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / datalogging (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 Metatarsal Bone 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as datalogging bolus and no more Intermittent Positive Pressure Ventilation datalogging mg / h (at the level of datalogging below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. Dosing and Administration of drugs: Impaired Fasting Glycaemia appoint 1 table. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. 0,025 grams of 0.075 datalogging to datalogging mg datalogging Mr injection 0,5% (5 mg / ml) for 2 sol. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) Finger-stick Blood Sugar patients with atherosclerosis, in combination with acetylsalicylic Point of Maximal Impulse in patients with coronary h. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / datalogging (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g datalogging dl), intracranial Endoscopic Ultrasonography isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding datalogging hypotension, etc.) when applying eptifibatida not different from that with High Altitude Pulmonary Edema Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, datalogging . (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Antiagrigant, antagonists of glycoprotein IIb / IIIA datalogging receptor. Indications for use of drugs: the risk of initial or repeat stroke in patients with datalogging thromboembolic or ischemic stroke, transient ischemic strokes, including here blindness prevention of ischemic complications in patients datalogging XP. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal.